1. "2019"
Formats
  1. Journal Article (2144)
  2. Meeting Abstract (2088)
  3. Review (529)
  4. Editorial (275)
  5. Book Section (252)
  6. Guidelines (108)
  7. Correspondence (89)
  8. Research Letter (47)
  9. Conference Paper (44)
  10. Miscellaneous (25)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2450)
  2. Solid Tumor Oncology Division (1408)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (937)
  6. Hematologic Malignancies, Division of (923)

More Groups

People
  1. Sergio Giralt (97)
  2. Marc Ladanyi (96)
  3. Maria Arcila (84)
  4. Miguel-Angel Perales (82)
  5. Alexander Drilon (76)
  6. David Hyman (74)

More People

Years
  1. 2019 (5611)
Publications
  1. Journal of Clinical Oncology (457)
  2. Blood (268)
  3. Cancer Research (192)
  4. Annals of Oncology (163)
  5. International Journal of Radiation Oncology, Biology, Physics (124)
  6. Modern Pathology (112)

More Publications

Publishers
  1. Elsevier Inc. (696)
  2. American Society of Clinical Oncology (518)
  3. Springer (445)
  4. American Association for Cancer Research (343)
  5. Nature Publishing Group (337)
  6. Oxford University Press (325)

More Publishers

Results (5611)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • FDA analysis: Impact of body mass index (BMI) on outcomes in relapsed-refractory multiple myeloma
    Meeting Abstract

    Ershler, R.; Kanapuru, B.; Gong, Y.; Shah, U. A.; Mailankody, S.; Landgren, O.; Theoret, M.; Gormley, N. J.; Farrell, A. T.; Pazdur, R.
    Blood (2019)

    Fulltext@MSK | Save
  • MALDI-TOF mass spectrometry in serum for the follow-up of newly diagnosed multiple myeloma patients treated with daratumumab-based combination therapy
    Meeting Abstract

    Eveillard, M.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Smith, E. L.; Hassoun, H.; Shah, U. A.; Lu, S. X.; Korde, N.; Landgren, O.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Dual driver mutant BCR-ABL1-negative myeloid neoplasms: Multicenter clinicopathologic and genomic analysis
    Meeting Abstract

    Epstein-Peterson, Z. D.; Tripodi, J.; Arcila, M. E.; Sen, F.; Najfeld, V.; Mascarenhas, J.; Hoffman, R.; Rampal, R. K.
    Blood (2019)

    Fulltext@MSK | Save
  • Contemporary outcomes in HTLV-1-associated adult T-cell leukemia/lymphoma: Single-institution experience
    Meeting Abstract

    Epstein-Peterson, Z. D.; Ghione, P.; Moskowitz, A. J.; Dahi, P. B.; Dogan, A.; Kumar, A.; Matasar, M. J.; Noy, A.; Perales, M. A.; Ponce, D. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • De novo myelodysplastic syndromes in patients 20-50 years old characterized by frequent mutations in TP53 and transcription-related genes
    Meeting Abstract

    Epstein-Peterson, Z. D.; Spitzer, B.; McCarter, J.; McGovern, E.; Levine, R. L.; Tallman, M. S.
    Blood (2019)

    Fulltext@MSK | Save
  • Combined targeting of the menin-MLL1 chromatin complex and FLT3 as a novel therapeutic concept against NPM1 mutant or MLL-rearranged AML with mutated FLT3
    Meeting Abstract

    Dzama, M. M.; Taubert, M. C.; Kunz, K.; Rausch, J.; Chen, C. W. D.; Mupo, A.; Hähnel, P.; Theobald, M.; Kindler, T.; Koche, R. P.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Unique regulatory pathways dictate the translational program in hematopoietic stem and progenitor cells
    Meeting Abstract

    Elias, H. K.; Spevak, C.; Kannan, L.; Ali, M. A. E.; Martin, G. H.; Selvaraj, S.; Eng, W. S.; Zhao, G.; Ernlund, A.; Rajasekhar, V.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • CD4 lymphocytes and T regulatory cells show distinct phenotypes in follicular lymphoma and classical Hodgkin lymphoma which may account for differences in responses to checkpoint therapy
    Meeting Abstract

    El Daker, S.; Gao, Q.; Roshal, M.; Dogan, A.
    Blood (2019)

    Fulltext@MSK | Save
  • Identifying cytokine biomarkers of response to pegylated-interferon therapy in polycythemia vera and essential thrombocythemia: Correlative analysis from the MPN-RC 111/112 trials
    Meeting Abstract

    Dunbar, A.; Kosiorek, H. E.; Krishnan, A.; McGovern, E.; Park, Y.; Patel, M. A.; Singer Weinberg, R.; Yacoub, A.; Dueck, A. C.; Mascarenhas, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • An individualized risk mitigation approach for safety: Experience from the mosunetuzumab (CD20/CD3 bispecific antibody) development program in relation to neurotoxicity risk
    Meeting Abstract

    Diefenbach, C.; Assouline, S.; Bosch, F.; Cheah, C. Y.; Kim, W. S.; Matasar, M. J.; Panizo, C.; Yoon, D. H.; Bender, B.; Hernandez, G.; more...
    Blood (2019)

    Fulltext@MSK | Save